Nesiritide enhances myocardial protection during the revascularization of acutely ischemic myocardium

Journal of Cardiac Surgery

Volumn 24, Issue 5, 2009, Pages 600-605

  Lazar, Harold L ^a   Bao, Yusheng ^a   Siwik, Deborah ^b   Frame, Jeffrey ^a   Mateo, Carlos San ^a   Colucci, Wilson S ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; NESIRITIDE; PLACEBO; BRAIN NATRIURETIC PEPTIDE; CARDIOTONIC AGENT; NATRIURETIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; REPERFUSION; REVASCULARIZATION; RISK ASSESSMENT; SWINE; UMBILICAL CORD BLOOD; VASODILATATION; ACUTE DISEASE; ANIMAL; CORONARY BLOOD VESSEL; DISEASE MODEL; DRUG EFFECTS; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; MYOCARDIAL ISCHEMIA; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; ANIMALS; CARDIOTONIC AGENTS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; SWINE;

EID: 69949165416     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2009.00865.x     Document Type: Article

References (24)

1. Colucci WS, Elkayam V, Horton DP : Intravenous nesiritide, a natriuretic peptide in the treatment of decompensated congestive heart failure. N Engl J Med 2000 343 : 246 253.
2. Levin ER, Gardner DG, Samson WK : Natriuretic peptides. N Engl J Med 1998 339 : 321 328.
3. Mills RM, LeJemtel TH, Horton DP : Sustained hemodynamic effects of an infusion of nesiritide (human B-type natriuretic peptide) in heart failure: A randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 1999 34 : 155 162.
4. Mentzer RM, Oz MC, Sladen RN, et al : Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery. The NAPA trial. J AM Coll Cardiol 2003 49 : 716 726.
5. Moazami N, Damiano RJ, Bailey MS, et al : Nesiritide (BNP) in the management of postoperative cardiac patients. Ann Thorac Surg 2003 75 : 1974 1976.
6. Salzberg SP, Filsoufi F, Anyanwu A, et al : High-risk mitral valve surgery: Perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005 80 : 502 506.
7. Sezai A, Shiono M, Orime Y, et al : Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 200 69 : 732 738.
8. Radovanceuk B, Vrtovec B, Yazdanbakhsh AP, et al : Perioperative use of nesiritide in heart failure patients undergoing implantation of left ventricular assist device. J Heart Lung Transplantation 2003 22 : S 201.
9. Tann SM, Ikonomidis JS, Uber W, et al : B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery. J Heart Lung Transplantation 2003 22 : S157.
10. Padilla F, Garcia-Dorado D, Agullo L : L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontractive and reduces infarct size in the pig. Cardiovasc Res 2000 46 : 412 420.
11. Padilla F, Garcia-Dorado D, Agullo L, et al : Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs. Cardiovasc Res 2001 51 : 592 600.
12. Wakui S. Experimental study on myocardial protection by adjunct use of Carperitide (hANP) in cardiac surgery. Ann Thorac Cardiovasc Surg 2005 11 : 12 20.
13. Lazar HL, Volpe C, Bao Y, et al : Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization. Ann Thorac Surg 1998 66 : 487 492.
14. Lazar HL, Bao Y, Tanzillo L, et al : Aprotinin decreases ischemic damage during coronary revascularization. J Cardiac Surg 2005 20 : 519 523.
15. Lazar HL, Bao Y, Zhang Y, et al : Pretreatment with statins enhances myocardial protection during coronary revascularization. J Thorac Cardiovasc Surg 2003 125 : 1037 1042.
16. Lazar HL, Bao Y, Gaudlani J, et al : Total complement inhibition: An effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass. Circ 1999 100 : 1438 1442.
17. Lazar HL, Zhang X, Rivers S, et al : Limiting ischemic damage during urgent revascularization using glucose-insulin-potassium solutions. Ann Thorac Surg 1995 60 : 411 416.
18. Nachlas MM, Shnitka TK : Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol 1963 42 : 379 384.
19. Hayashi M, Tsutamoto T, Wada A, et al : Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 2001 37 : 1820 1826.
20. Chen HH, Sundt TM, Cook DJ, et al : Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary bypass surgery. A double-blind placebo-controlled pilot study. Circ 2007 116 (Suppl I I134 I138.
21. Insente J, Garcia-Dorado D, Agullo L, et al : Urodilatin limits acute reperfusion injury in the isolated rat heart. Cardiovasc Res 2000 45 : 351 359.
22. Michaels AD, Klein A, Madden JA, et al : Effects of intravenous Nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation 2003 107 : 2697 2701.
23. Okumura K, Yasue H, Fujii H, et al : Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: Comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol 1995 25 : 342 348.
24. Costa AD, Pierre SV, Cohen MV, et al : cGMP signaling in pre and post conditioning: the role of mitochondria. Cardiovasc Res. 2008 : 77 : 344 352.